MedTrace Logo

ChitoCare Medical Wound Healing Gel PMCF Study on Healing of Chronic Wounds

NCT05570877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2025-02-19

No results posted yet for this study

Summary

We are testing a gel intended for the protection and healing of chronic wounds as a support for standard therapy. The main component of the gel is chitosan, a natural polymer that has the ability to stop bleeding, has a positive effect on wound healing, and has antimicrobial properties.

Conditions

  • Diabetic Foot Ulcer
  • Venous Leg Ulcer
  • Pressure Ulcer

Interventions

DEVICE

ChitoCare medical Wound Healing Gel

ChitoCare medical Wound Healing Gel is a CE-marked medical device.

Sponsors & Collaborators

  • Vizera d.o.o.

    collaborator INDUSTRY

  • University of Ljubljana

    collaborator OTHER

  • Primex ehf

    lead INDUSTRY

Principal Investigators

  • Helene Liette Lauzon · Primex ehf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-11
Primary Completion
2024-10-15
Completion
2024-10-15

Countries

  • Croatia
  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570877 on ClinicalTrials.gov